Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with FDA 6,421 headlines found

3 Views

FDA Panel: Chantix Boxed Warning Should Stay

Action Points: An FDA advisory committee voted overwhelmingly that varenicline (Chantix), a drug to help people stop smoking, should continue to carry a boxed warning about the risk of severe neuropsychiatric events, with several panel members suggesting
MedPage Today
added Oct 23, 2014 13:06
5 Views

Regulate E-Cigs Sooner, Not Later

Carefully crafted regulatory control can provide a "national harm-reduction framework," Nathan K. Cobb, MD, and David B. Abrams, PhD, of Georgetown University in Washington and Johns Hopkins Bloomberg School of Public Health, wrote in the New England Jour
MedPage Today
added Oct 23, 2014 09:20
9 Views

COBB/ABRAMS: The FDA, E-Cigarettes, and the Demise of Combusted Tobacco

We would encourage the FDA to accelerate their regulations to eliminate uncertainty regarding safety, drive the substitution and use of clean nicotine, and hasten the demise of lethal combusted tobacco.
New England Journal of Medicine (NEJM)
added Oct 17, 2014 16:29
5 Views

AUDIO: Interview with Dr. Nathan Cobb on the future of e-cigarettes, smoking, nicotine-replacement therapy, and Big Tobacco.

Nathan Cobb is an attending physician in pulmonary and critical care medicine at Georgetown University Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal.
New England Journal of Medicine (NEJM)
added Oct 17, 2014 16:24
5 Views

NEJM Perspective: 'The FDA, e-cigarettes, and the demise of combusted tobacco'

The popularity of E-cigarettes could lead to the "demise" of cigarette smoking and save thousands of lives, but not until they are proven safe and are regulated by the U.S. Food and Drug Administration (FDA). That's the message from two Georgetown Univers
Science Codex
added Oct 17, 2014 16:20
5 Views

FDA Panel: Chantix Boxed Warning Should Stay

Action Points An FDA advisory committee voted overwhelmingly that varenicline (Chantix), a drug to help people stop smoking, should continue to carry a boxed warning about the risk of severe neuropsychiatric events, with several panel members suggesting i
MedPage Today
added Oct 17, 2014 13:15
4 Views

FDA panel votes to keep severe warning on Pfizer anti-smoking drug

Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.
Reuters
added Oct 16, 2014 23:39
7 Views

Accounting for “Lost Pleasure” in a Cost–Benefit Analysis of Government Regulation: The Case of the FDA's Proposed Cigarette Labeling Regulation ($$)

Annals of Internal Medicine
added Oct 16, 2014 20:35
15 Views

'Lost pleasure' from smoking not a cost in economic analyses

"Lost pleasure" represented by consumer surplus should not be considered in economic impact analyses of tobacco regulation, according to an ideas and opinions piece published online Oct. 14 in the Annals of Internal Medicine.
Medical Xpress (PhysOrg.com)
added Oct 16, 2014 20:33
2 Views

FDA Panel: Chantix Boxed Warning Should Stay

An FDA advisory committee voted overwhelmingly that the stop-smoking drug should continue to carry a boxed warning about the risk of severe neuropsychiatric events, with several panel members suggesting it should be strengthened.
MedPage Today
added Oct 16, 2014 17:46
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines